Levels of E2A protein expression in B cell precursors are stage-dependent and inhibited by stem cell factor (c-kit ligand)

Experimental Hematology

Volumn 30, Issue 12, 2002, Pages 1412-1418

  Riley, Richard L ^a   Knowles, Jennean ^a   King, Anne M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; FLT3 LIGAND; MESSENGER RNA; PROTEIN; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 7; SOMATOMEDIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CULTURE; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; STEM CELL FACTOR; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

MURINAE;

EID: 0036898290     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00953-0     Document Type: Article

References (27)

1. Lee B.L., Quong M.W., Murre C. E2A proteins. essential regulators at multiple stages of B cell development Immunol Rev. 175:2000;138.
2. Bain G., Murre C. The role of E-proteins in B- and T-lymphocyte development. Semin Immunol. 10:1998;143.
3. Glimcher L.H., Singh H. Transcription factors in lymphocyte development - T and B cells get together. Cell. 96:1999;12.
4. Zhuang Y., Soriano P., Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell. 79:1994;875.
5. Bain G., Robanus Maandag E., te Riele H.et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity. 6:1997;145.
6. Xin X.Q., Nelson C., Collins L., Dorshkind K. Kinetics of E2A basic helix-loop-helix protein expression during myelopoiesis and primary B cell differentiation. J Immunol. 151:1993;5398.
7. Murre C., Voronova A., Baltimore D. B-cell and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol Cell Biol. 11:1991;1156.
8. Herblot S., Aplan P.D., Hoang T. Gradient of E2A activity in B-cell development. Mol Cell Biol. 22:2002;886.
9. Ogawa M., Nishikawa S., Ikuta K.et al. Expression and function of c-kit in hemotopoietic progenitor cells. J Exp Med. 174:1991;63.
10. Era T., Nishikawa S., Sudo T.et al. How B-cell precursors are driven into cycle. Immunol Rev. 137:1994;35.
11. Rolink A., Grawunder U., Winkler T.H., Karasuyama H., Melchers F. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol. 6:1994;1257.
12. Sherwood E.M., Blomberg B.B., Xu W., Warner C.A., Riley R.L. Senescent BALB/c mice exhibit decreased expression of λ5 surrogate light chains and reduced development within the pre-B cell compartment. J Immunol. 161:1998;4472.
13. Sherwood E.M., Xu W., King A.M., Blomberg B.B., Riley R.L. The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins. Mech Ageing Dev. 118:2000;45.
14. Choi Y.H., Lee S.J., Nguyen P.M.et al. Regulation of cyclin D1 by calpain protease. J Biol Chem. 272:1997;28479.
15. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pre-pro B cell stages in normal mouse bone marrow. J Exp Med. 173:1991;1213.
16. Shinjo F., Hardy R.R., Jongstra J. Monoclonal anti-λ 5 antibody FS1 identifies a 130 kDa protein associated with λ 5 and Vpre-B on the surface of early pre-B cell lines. Int Immunol. 6:1994;393.
17. Sigvardsson M., O'Riordan M., Grosschedl R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity. 7:1997;25.
18. McNiece I.K., Langley K.E., Zsebo K.M. The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL- 7. J Immunol 146:1991;3785.
19. Hirayama F., Lyman S.D., Clark S.C., Ogawa M. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood. 85:1995;1762.
20. Landreth K.S., Ramaswamy N., Dorshkind K. Insulin-like growth factor-1 regulates pro-B cell differentiation. Blood. 80:1992;1207.
21. Kho C.J., Huggins G.S., Endege W.O., Hsieh C.M., Lee M.E., Haber E. Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A. J Biol Chem. 272:1997;3845.
22. Huggins G.S., Chin M.T., Sibinga N.E.S., Lee S.-L., Haber E., Lee M.-E. Characterization of the mUBC9-binding sites required for E2A protein degradation. J Biol Chem. 274:1999;28690.
23. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem Sci. 1996 21:1996;267.
24. Baird A.M., Gerstein R.M., Berg L.J. The role of cytokine receptor signaling in lymphocyte development. Curr Opin Immunol. 11:1999;157.
25. Quong M.W., Harris D.P., Swain S.L., Murre C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18:1999;6307.
26. Zhao F., Vilardi A., Neely R.J., Choi K. Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol Cell Biol. 21:2001;6346.
27. Romanow W.J., Langerak A.W., Goebel P.et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell. 5:2000;343.